A critical discovery in cancer research is arising with the use of mini-antibodies to reactivate mutated p53. This essential cancer inhibitor protein is frequently inactivated in various types of malignancies, https://social-medialink.com/story7016517/mini-antibodies-reactivate-the-p53-protein-a-new-approach-for-cancer-management